The enzyme associated with the conversion of androgen to oestrogen in the growing ovarian follicle is:
Androgens like testosterone are precursors to estrogen. The key enzyme here is aromatase. Aromatase is responsible for the aromatization of androgens to estrogens. It's part of the cytochrome P450 family, specifically CYP19A1. This enzyme is present in granulosa cells of the ovarian follicles, which are stimulated by FSH.
Now, the incorrect options might include other enzymes like 5-alpha reductase, which converts testosterone to DHT, or 17-beta hydroxysteroid dehydrogenase, which converts androstenedione to testosterone. Another possible distractor could be 3-beta hydroxysteroid dehydrogenase, which is involved in earlier steps of steroidogenesis.
The clinical pearl here is that aromatase inhibitors are used in breast cancer treatment to block estrogen production. Also, in PCOS, aromatase activity might be altered, leading to higher androgen levels.
I need to structure the explanation clearly, making sure each section addresses the core concept, correct answer, incorrect options, and the clinical pearl. Keep it concise but thorough, using proper medical terms for searchability.
**Core Concept**
The conversion of androgens (e.g., testosterone) to estrogens (e.g., estradiol) in ovarian follicles relies on **aromatase**, a cytochrome P450 enzyme (CYP19A1). This reaction occurs in granulosa cells under follicle-stimulating hormone (FSH) stimulation and is critical for estrogen biosynthesis in the ovary.
**Why the Correct Answer is Right**
**Aromatase** catalyzes the aromatization of androgens (testosterone and androstenedione) to estrogens (estradiol and estrone). It performs this by removing the 19th carbon from the androgen backbone, creating the aromatic A-ring structure characteristic of estrogens. This enzyme is localized in granulosa cells, where it works synergistically with theca cells to produce estrogen via the two-cell-two-gonadotropin model.
**Why Each Wrong Option is Incorrect**
**Option A:** *5α-reductase* converts testosterone to dihydrotestosterone (DHT), a more potent androgen, not estrogen.
**Option B:** *17β-hydroxysteroid dehydrogenase* converts androstenedione to testosterone, progressing along the androgen synthesis pathway.
**Option C:** *3β-hydroxysteroid dehydrogenase* is involved in earlier steps of steroidogenesis, converting pregnenolone to progesterone, not estrogen.
**Clinical Pearl / High-Yield Fact**
Aromatase inhibitors (e.g., letrozole) are used in breast cancer treatment to block estrogen production in postmenopausal women. In polycystic ovary syndrome (PCOS), excessive androgen production may reflect dysregulated aromatase activity in peripheral tissues.
**Correct Answer: C. Aromatase**